{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:30:50Z","timestamp":1740133850146,"version":"3.37.3"},"reference-count":21,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["208053\/B\/17\/Z","218092\/A\/19\/Z"],"award-info":[{"award-number":["208053\/B\/17\/Z","218092\/A\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015873","name":"National Brain Appeal","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100015873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_21046","MR\/S002065\/1","MR\/S005021\/1"],"award-info":[{"award-number":["MC_PC_21046","MR\/S002065\/1","MR\/S005021\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022186","name":"Lily Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100022186","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Ethics"],"accepted":{"date-parts":[[2023,6,8]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>We discuss a case where clinical genomic investigation of muscle weakness unexpectedly found a genetic variant that might (or might not) predispose to kidney cancer. We argue that despite its off-target and uncertain nature, this variant should be discussed with the man who had the test, not because it is medical information, but because this discussion would allow the further clinical evaluation that might lead it to becoming so. We argue that while prominent ethical debates around genomics often take \u2018results\u2019 as a starting point and ask questions as to whether to look for and how to react to them, the construction of genomic results is fraught with ethical complexity, although often couched as a primarily technical problem. We highlight the need for greater focus on, and appreciation of, the ethical work undertaken daily by scientists and clinicians working in genomic medicine and discuss how public conversations around genomics need to adapt to prepare future patients for potentially uncertain and unexpected outcomes from clinical genomic tests.<\/jats:p>","DOI":"10.1136\/jme-2023-109108","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T17:20:18Z","timestamp":1687281618000},"page":"295-298","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance"],"prefix":"10.1136","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6080-6354","authenticated-orcid":false,"given":"Rachel H","family":"Horton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L","family":"Macken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D S","family":"Pitceathly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3324-4338","authenticated-orcid":false,"given":"Anneke M","family":"Lucassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"2024052220003580000_50.5.295.1","unstructured":"NHS England . NHS Genomic Medicine Service. n.d. Available: https:\/\/www.england.nhs.uk\/genomics\/nhs-genomic-med-service\/"},{"key":"2024052220003580000_50.5.295.2","doi-asserted-by":"publisher","DOI":"10.1038\/nature15393"},{"key":"2024052220003580000_50.5.295.3","doi-asserted-by":"crossref","DOI":"10.1038\/nrg.2018.12","article-title":"Paediatric genomics: diagnosing rare disease in children","volume":"19","author":"Wright","year":"2018","journal-title":"Nat Rev Genet"},{"key":"2024052220003580000_50.5.295.4","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2024052220003580000_50.5.295.5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","article-title":"Mapping the human genetic architecture of COVID-19","volume":"600","year":"2021","journal-title":"Nature"},{"key":"2024052220003580000_50.5.295.6","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF V3.0 list for reporting of secondary findings in clinical Exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"key":"2024052220003580000_50.5.295.7","unstructured":"100,000 genomes project. Additional findings. n.d. Available: https:\/\/www.genomicsengland.co.uk\/information-for-participants\/additional-findings\/"},{"key":"2024052220003580000_50.5.295.8","unstructured":"Office for Life Sciences, Department of Health and Social Care, Department for Science, Innovation and Technology, Department for Business . Energy and industrial strategy, Lord Bethell of Romford. Genome UK: the future of healthcare. n.d. Available: https:\/\/www.gov.uk\/government\/publications\/genome-uk-the-future-of-healthcare2020"},{"key":"2024052220003580000_50.5.295.9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41431-019-0504-4","article-title":"Genome sequencing in healthcare: understanding the UK general public\u2019s views and implications for clinical practice","volume":"28","author":"Ballard","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"2024052220003580000_50.5.295.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1507092"},{"key":"2024052220003580000_50.5.295.11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10689-018-0086-2","article-title":"Physician interpretation of variants of uncertain significance","volume":"18","author":"Macklin","year":"2019","journal-title":"Fam Cancer"},{"key":"2024052220003580000_50.5.295.12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12687-018-0375-3","article-title":"Experiences of patients seeking to participate in variant of uncertain significance reclassification research","volume":"10","author":"Makhnoon","year":"2019","journal-title":"J Community Genet"},{"key":"2024052220003580000_50.5.295.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.12.015"},{"key":"2024052220003580000_50.5.295.14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41431-019-0570-7","article-title":"Exploring broad consent in the context of the 100,000 genomes project: a mixed methods study","volume":"28","author":"Ballard","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"2024052220003580000_50.5.295.15","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2013.165"},{"key":"2024052220003580000_50.5.295.16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gim.2021.08.010","article-title":"Decision-making, attitudes, and understanding among patients and relatives invited to undergo genome sequencing in the 100,000 Genomes project: a multisite survey study","volume":"24","author":"Sanderson","year":"2022","journal-title":"Genet Med"},{"key":"2024052220003580000_50.5.295.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.o1779","article-title":"The NHS is not living with Covid, it\u2019s dying from it","volume":"378","author":"McLellan","year":"2022","journal-title":"BMJ"},{"key":"2024052220003580000_50.5.295.18","unstructured":"Raz J . The morality of freedom. Oxford: Clarendon, 1986."},{"key":"2024052220003580000_50.5.295.19","unstructured":"El Mecky J . Constructing medical test results: the social shaping of genetic results and their (Un)certainty. University of Southampton, 2021."},{"key":"2024052220003580000_50.5.295.20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40142-019-00164-9","article-title":"Consent and autonomy in the genomics era","volume":"7","author":"Horton","year":"2019","journal-title":"Curr Genet Med Rep"},{"key":"2024052220003580000_50.5.295.21","doi-asserted-by":"crossref","unstructured":"Manson NC . The scope of consent. In: Schaber P , Muller A , eds. The Routledge handbook of the ethics of consent. Routledge, 2018: 65\u201374. doi:10.4324\/9781351028264","DOI":"10.4324\/9781351028264-7"}],"container-title":["Journal of Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jme-2023-109108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T03:04:16Z","timestamp":1716433456000},"score":1,"resource":{"primary":{"URL":"https:\/\/jme.bmj.com\/lookup\/doi\/10.1136\/jme-2023-109108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,9]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/jme-2023-109108"],"URL":"https:\/\/doi.org\/10.1136\/jme-2023-109108","relation":{},"ISSN":["0306-6800","1473-4257"],"issn-type":[{"type":"print","value":"0306-6800"},{"type":"electronic","value":"1473-4257"}],"subject":[],"published":{"date-parts":[[2023,6,20]]}}}